{"created":"2023-06-19T07:25:44.586594+00:00","id":13797,"links":{},"metadata":{"_buckets":{"deposit":"34240c67-f1c4-4449-8ef7-22d089c2fb93"},"_deposit":{"created_by":81,"id":"13797","owners":[81],"pid":{"revision_id":0,"type":"depid","value":"13797"},"status":"published"},"_oai":{"id":"oai:gifu-pu.repo.nii.ac.jp:00013797","sets":["212:275:282"]},"author_link":["29765","29768","29771","29766","29769","29767","29772","29770"],"item_3_biblio_info_3":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-05","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"46","bibliographicPageStart":"38","bibliographicVolumeNumber":"137","bibliographic_titles":[{},{"bibliographic_title":"Journal of pharmacological sciences","bibliographic_titleLang":"en"}]}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"3T3 Cells","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Adipocytes","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Animals","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Benzamides","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Biphenyl Compounds","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Cell Differentiation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Diabetes Mellitus, Experimental","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Dose-Response Relationship, Drug","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Enzyme Inhibitors","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Hep G2 Cells","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Humans","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Insulin","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Leptin","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Male","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Mice","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Mice, Inbred C57BL","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Mice, Inbred Strains","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Molecular Targeted Therapy","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Obesity","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Phosphorylation","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Protein Tyrosine Phosphatase, Non-Receptor Type 1","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"STAT3 Transcription Factor","subitem_subject_language":"en","subitem_subject_scheme":"Other"},{"subitem_subject":"Signal Transduction","subitem_subject_language":"en","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice.","subitem_title_language":"en"}]},"item_type_id":"3","owner":"81","path":["282"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-03-04"},"publish_date":"2020-03-04","publish_status":"0","recid":"13797","relation_version_is_last":true,"title":["Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice."],"weko_creator_id":"81","weko_shared_id":-1},"updated":"2023-06-19T07:49:12.657100+00:00"}